Down-regulation of epithelial IL-8 responses in Helicobacter pylori-infected duodenal ulcer patients depends on host factors, rather than bacterial factors

Clinical and Experimental Immunology

Volumn 140, Issue 1, 2005, Pages 117-125

  Strömberg, Erika ^a   Edebo, A ^a   Lundin, B S ^a   Bergin, P ^a   Brisslert, M ^a   Svennerholm, A M ^a   Lindholm, C ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Cytokines; Duodenal ulcer; Duodenum; Epithelium; Helicobacter pylori; Mucosa; Receptor; T cell

Indexed keywords

CYTOKINE; INTERLEUKIN 8;

ARTICLE; CHRONIC INFLAMMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DUODENUM ULCER; EPITHELIUM CELL; GASTROINTESTINAL INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; IMMUNE RESPONSE; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; RISK FACTOR; STRAIN IDENTIFICATION; SYMPTOMATOLOGY;

CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; COCULTURE TECHNIQUES; DOWN-REGULATION; DUODENAL ULCER; EPITHELIAL CELLS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTERLEUKIN-8; INTESTINAL MUCOSA; RECEPTORS, CYTOKINE; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA;

EID: 16244390527     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2005.02736.x     Document Type: Article

References (56)

1. Kuipers EJ, Thijs JC, Festen HP. The prevalence of Helicobacter pylori in peptic ulcer disease. Alimentary Pharmacol Therapeutics 1995; 9 (Suppl. 2):59-69.
2. Blaser MJ, Perez-Perez GI, Kleanthous H et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55:2111-5.
3. Hamlet A, Thoreson AC, Nilsson O et al. Duodenal Helicobacter pylori infection differs in cagA genotype between asymptomatic subjects and patients with duodenal ulcers. Gastroenterology 1999; 116:259-68.
4. JL Telford Ghiara P Dell'Orco M, et al. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J Exp Med 1994; 179:1653-8.
5. JC Atherton RM Peek Jr. KT Thamet al. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology 1997; 112:92-9.
6. LJ van Doom C Figueiredo R Sanna et al. Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology 1998; 115:58-66.
7. D Ilver A Arnqvist J Ogren et al. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 1998; 279 (5349):373-7.
8. B Singh S Read C Asseman et al. Control of intestinal inflammation by regulatory T cells. Immunol Rev 2001; 182:190-200.
9. K Nakamura Kitani A Strober W. Cell contact-dependent immunosuppression by CD4 (+) CD25 (+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 2001; 194:629-44.
10. S Read Malmstrom V Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25 (+) CD4 (+) regulatory cells that control intestinal inflammation. J Exp Med 2000; 192:295-302.
11. S Raghavan M Hjulstrom J Holmgren et al. Protection against experimental Helicobacter pylori infection after immunization with inactivated H. pylori whole-cell vaccines. Infection Immunity 2002; 70:6383-8.
12. Raghavan S, Fredriksson M, Svennerholm AM et al. Absence of CD4+CD25+ regulatory T cells is associated with a loss of regulation leading to increased pathology in Helicobacter pylori-infected mice. Clin Exp Immunol 2003; 132:393-400.
13. Lundgren A, Suri-Payer E, Enarsson K et al. Helicobacter pylori-specific CD4+ CD25high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals. Infection Immunity 2003; 71:1755-62.
14. Lindholm C, Quiding-Jarbrink M, Lonroth H et al. Local cytokine response in Helicobacter pylori-infected subject. Infection Immunity 1998; 66:5964-71.
15. Stromberg E, Edebo A, Svennerholm AM et al. Decreased epithelial cytokine responses in the duodenal mucosa of Helicobacter pylori-infected duodenal ulcer patients. Clin Diagnostic Laboratory Immunol 2003; 10:116-24.
16. Stromberg E, Lundgren A, Edebo A et al. Increased frequency of activated T-cells in the Helicobacter pylori-infected antrum and duodenum. FEMS Immunol Med Microbiol 2003; 36:159-68.
17. Thoreson AC, Hamlet A, Celik J et al. Differences in surface-exposed antigen expression between Helicobacter pylori strains isolated from duodenal ulcer patients and from asymptomatic subjects. J Clin Microbiol 2000; 38:3436-41.
18. Lindholm C, Quiding-Jarbrink M, Lonroth H et al. Induction of chemokine and cytokine responses by Helicobacter pylori in human stomach explants. Scand J Gastroenterol 2001; 36:1022-9.
19. Lundin BS, Johansson C, Svennerholm AM. Oral immunization with a Salmonella enterica serovar typhi vaccine induces specific circulating mucosa-homing CD4 (+) and CD8 (+) T cells in humans. Infection Immunity 2002; 70:5622-7.
20. Crowe SE, Alvarez L, Dytoc M et al. Expression of interleukin 8 and CD54 by human gastric epithelium after Helicobacter pylori infection in vitro. Gastroenterology 1995; 108:65-74.
21. Huang J, O'Toole PW, Doig P et al. Stimulation of interleukin-8 production in epithelial cell lines by Helicobacter pylori. Infection Immunity 1995; 63:1732-8.
22. Jung HC, Kim JM, Song IS et al. Helicobacter pylori induces an array of pro-inflammatory cytokines in human gastric epithelial cells: quantification of mRNA for interleukin-8-1 alpha/beta, granulocyte-macrophage colony-stimulating factor, monocyte chemoattractant protein-1 and tumour necrosis factor-alpha. J Gastroenterol Hepatol 1997; 12:473-80.
23. Innocenti M, Thoreson AC, Ferrero RL et al. Helicobacter pylori-induced activation of human endothelial cells. Infection Immunity 2002; 70:4581-90.
24. Crabtree JE, Farmery SM, Lindley IJ et al. CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines. J Clin Pathol 1994; 47:945-50.
25. Shimoyama T, Everett SM, Dixon MF et al. Chemokine mRNA expression in gastric mucosa is associated with Helicobacter pylori cagA positivity and severity of gastritis. J Clin Pathol 1998; 51:765-70.
26. Yamaoka Y, Kita M, Kodama T et al. Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa. Gastroenterology 1996; 110:1744-52.
27. Boismenu R, Havran WL. Modulation of epithelial cell growth by intraepithelial gamma delta T cells. Science 1994; 266:1253-5.
28. Colgan SP, Parkos CA, Matthews JB et al. Interferon-gamma induces a cell surface phenotype switch on T84 intestinal epithelial cells. Am J Physiol 1994; 267:C402-10.
29. Horie Y, Chiba M, Suzuki T et al. Induction of major histocompatibility complex class II antigens on human colonic epithelium by interferon-gamma, tumor necrosis factor-alpha, and interleukin-2. J Gastroenterol 1998; 33:39-47.
30. Kaoutzani P, Colgan SP, Cepek KL et al. Reconstitution of cultured intestinal epithelial monolayers with a mucosal-derived T lymphocyte cell line. Modulation of epithelial phenotype dependent on lymphocyte-basolateral membrane apposition. J Clin Invest 1994; 94:788-96.
31. Mohammadi M, Czinn S, Redline R et al. Helicobacter-specific cell-mediated immune responses display a predominant Th1 phenotype and promote a delayed-type hypersensitivity response in the stomachs of mice. J Immunol 1996; 156:4729-38.
32. Sawai N, Kita M, Kodama T et al. Role of gamma Interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model. Infection Immunity 1999; 67:279-85.
33. Abreu MT, Arnold ET, Thomas LS et al. TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells. J Biol Chem 2002; 277:20431-7.
34. F Backhed B Rokbi E Torstensson et al. Gastric mucosal recognition of Helicobacter pylori is independent of Toll-like receptor 4. J Infectious Dis 2003; 187:829-36.
35. Goke M, Podolsky DK. Regulation of the mucosal epithelial barrier. Baillieres Clin Gastroenterol 1996; 10:393-405.
36. Moss SF, Calam J, Agarwal B et al. Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut 1996; 38:498-501.
37. Wagner S, Beil W, Westermann J et al. Regulation of gastric epithelial cell growth by Helicobacter pylori: offdence for a major role of apoptosis. Gastroenterology 1997; 113:1836-47.
38. Raqib R, Lindberg AA, Bjork L et al. Down-regulation of gamma interferon, tumor necrosis factor type I, interleukin 1 (IL-1) type I, IL-3, IL-4, and transforming growth factor beta type I receptors at the local site during the acute phase of Shigella infection. Infection Immunity 1995; 63:3079-87.
39. Lundgren SE, Sjöling A, Lindholm Å et al. Mucosal FOXP3-expressing CD4+CD25high regulatory T cells in Helicobacter pylori-infected patients. Infection and Immunity 2004.
40. Shevach EM, CD4+ CD25+ suppressor T cells: more questions than answers. Nature Rev Immunol 2002; 2:389-400.
41. Thompson CB, Allison JP. The emerging role of CTLA-4 as an immune attenuator. Immunity 1997; 7:445-50.
42. Krummel MF, Allison JP. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J Exp Med 1996; 183:2533-40.
43. Alegre ML, Shiels H, Thompson CB et al. Expression and function of CTLA-4 in Th1 and Th2 cells. J Immunol 1998; 161:3347-56.
44. Cederbom L, Hall H, Ivars F. CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. European J Immunol 2000; 30:1538-43.
45. Hershberg RM, Mayer LF. Antigen processing and presentation by intestinal epithelial cells - polarity and complexity. Immunol Today 2000; 21:123-8.
46. Archimandritis A, Sougioultzis S, Foukas PG et al. Expression of HLA-DR, costimulatory molecules B7-1, B7-2, intercellular adhesion molecule-1 (ICAM-1) and Fas ligand (FasL) on gastric epithelial cells in Helicobacter pylori gastritis; influence of H. pylori eradication. Clinical & Experimental Immunology 2000; 119:464-71.
47. Ye G, Barrera C, Fan X et al. Expression of B7-1 and B7-2 costimulatory molecules by human gastric epithelial cells: potential role in CD4+ T cell activation during Helicobacter pylori infection. J Clin Invest 1997; 99:1628-36.
48. El-Omar EM, Carrington M, Chow WH et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer, [erratum appears in Nature 2001; 412:99.]. Nature 2000; 404:398-402.
49. El-Omar EM, Carrington M, Chow WH et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer, [erratum appears in Nature 2001; 412:99.]. Nature 2000; 404:398-402.
50. Garcia-Gonzalez MA, Lanas A, Santolaria S et al. The polymorphic IL-1B and IL-1RN genes in the aetiopathogenesis of peptic ulcer. Clin Exp Immunol 2001; 125:368-75.
51. Lanas A, Garcia-Gonzalez MA, Santolaria S et al. TNF and LTA gene polymorphisms reveal different risk in gastric and duodenal ulcer patients. Genes Immunity 2001; 2:415-21.
52. Planchon S, Fiocchi C, Takafuji V et al. Transforming growth factor-beta1 preserves epithelial barrier function: identification of receptors, biochemical intermediates, and cytokine antagonists. J Cellular Physiol 1999; 181:55-66.
53. Roche JK, Martins CA, Cosme R et al. Transforming growth factor beta1 ameliorates intestinal epithelial barrier disruption by Cryptosporidium parvum in vitro in the absence of mucosal T lymphocytes. Infection Immunity 2000; 68:5635-44.
54. Godaly G, Proudfoot AE, Offord RE et al. Role of epithelial interleukin-8 (IL-8) and neutrophil IL-8 receptor A in Escherichia coli-induced transuroepithelial neutrophil migration. Infection Immunity 1997; 65:3451-6.
55. Hang L, Frendeus B, Godaly G et al. Interleukin-8 receptor knock-out mice have subepithelial neutrophil entrapment and renal scarring following acute pyelonephritis. J Infectious Dis 2000; 182:1738-18.
56. Zhang Q, Dawodu JB, Etolhi G et al. Relationship between the mucosal production of reactive oxygen radicals and density of Helicobacter pylori in patients with duodenal ulcer. European J Gastroenterol Hepatol 1997; 9:261-5.